Canada is settling for half measures on drug price regulations

Globe and Mail

22 April 2022 - After a two-year delay, new federal regulations for patented medicine prices will come into force this summer – but without key rules designed to prevent price gouging. 

Politics and court rulings got in the way of Canada applying what would have been a global innovation in pharmaceutical price regulation.

Patented drug pricing and related regulation is complex. But the gist of what Canada has decided to do – and decided not to do – can be understood if you have ever rented a hotel room.

Read Globe and Mail article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , Regulation , Pricing , Canada